LOPERAMIDE HYDROCHL

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC with CAGE code 1UNB0 for the supply of 10.000 packages of LOPERAMIDE HYDROCHLORIDE, identified by NSN 6505015495732, at a total contract value of $8.00. The award was issued on July 14, 2026, with a single delivery requirement to be completed on or before July 29, 2026, at Fort Bragg, North Carolina, under FOB Destination terms, meaning the contractor bears all freight costs and risks until delivery is completed at the designated military location. The product must conform to contract specifications, and inspection and acceptance are conducted by the Government upon receipt. Invoicing must be submitted electronically through Wide Area WorkFlow in accordance with DFARS 252.232-7003, and payments will be processed by the Defense Finance and Accounting Service in Columbus, Ohio. The contract reflects a low-dollar-value procurement typical of DLA’s pharmaceutical supply chain, with no option quantities, variance permitted, or special requirements beyond standard logistical directives, such as using traceable shipping methods and excluding parcel post. Labeling includes the NSN, NDC numbers, CAGE codes, and tracing control numbers consistent with Department of Defense supply chain practices, though no explicit compliance with MIL-STDs for packaging, preservation, or barcoding is stated. The awardee’s size status and socioeconomic certifications are not specified, and no evaluation factors, contract clauses, or attachments are detailed beyond administrative and payment logistics. The contract is administered by DLA Troop Support’s Medical Supply Chain, Pharmaceutical FSA, with Shairy M. Cartagena as the primary point of contact.